License Royalties. 5.2.1 In consideration of the rights and licence granted to Acorda to the Elan Patent Rights by virtue of the SCI Agreement, Acorda has paid to Elan $5,000,000 (five million United States Dollars); and 5.2.2 In consideration of the rights and licence granted to MS R & D to the Elan Patent Rights by virtue of the MS Agreement, MS R & D has paid to Elan $15,000,000 (fifteen million United States Dollars) β receipt of each of which is hereby acknowledged by Elan.
Appears in 6 contracts
Samples: License Agreement, License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)